Bupivacaine is an effective potassium channel blocker in heart
1988; Elsevier BV; Volume: 939; Issue: 1 Linguagem: Inglês
10.1016/0005-2736(88)90058-2
ISSN1879-2642
AutoresKenneth R. Courtney, Joan J. Kendig,
Tópico(s)Analytical Chemistry and Sensors
ResumoThe local anesthetic agent bupivacaine increases action potential duration in isolated frog atrial myocytes, and blocks two potassium conductances, IK and IK1. The effective concentrations, particularly for IK, are similar to those which depress the sodium conductance. Potassium channel block may thus contribute to bupivacaine's reported cardiotoxicity.
Referência(s)